The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Systematic Evaluation of Serotypes Causing Invasive Pneumococcal Disease among Children Under Five: The Pneumococcal Global Serotype Project
Open accessAbstract
BACKGROUND: Approximately 800,000 children die each year due to pneumococcal disease and >90% of these deaths occur in developing countries where few children have access to life-saving serotype-based vaccines. Understanding the serotype epidemiology of invasive pneumococcal disease (IPD) among children is necessary for vaccine development and introduction policies. The aim of this study was to systematically estimate the global and regional distributions of serotypes causing IPD in children <5 years of age. METHODS AND FINDINGS: We systematically reviewed studies with IPD serotype data among children <5 years of age from the published literature and unpublished data provided by researchers. Studies conducted prior to pneumococcal conjugate vaccine (PCV) introduction, from 1980 to 2007, with ≥12 months of surveillance, and reporting ≥20 serotyped isolates were included. Serotype-specific proportions were pooled in a random effects meta-analysis and combined with PD incidence and mortality estimates to infer global and regional serotype-specific PD burden. Of 1,292, studies reviewed, 169 were included comprising 60,090 isolates from 70 countries. Globally and regionally, six to 11 serotypes accounted for ≥70% of IPD. Seven serotypes (1, 5, 6A, 6B, 14, 19F, 23F) were the most common globally; and based on year 2000 incidence and mortality estimates these seven serotypes accounted for >300,000 deaths in Africa and 200,000 deaths in Asia. Serotypes included in both the 10- and 13-valent PCVs accounted for 10 million cases and 600,000 deaths worldwide. CONCLUSIONS: A limited number of serotypes cause most IPD worldwide. The serotypes included in existing PCV formulations account for 49%-88% of deaths in Africa and Asia where PD morbidity and mortality are the highest, but few children have access to these life-saving vaccines. Please see later in the article for the Editors' Summary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230
The Design and Analysis of Clinical Experiments
Fleiss, J. L. (1999) · Wiley eBooks · doi:10.1002/9781118032923 · Cited by 4,819
The Design and Analysis of Clinical Experiments.
Hills, M., & Fleiss, J. L. (1987) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2982050 · Cited by 3,261
O'Brien, K. L., Wolfson, L. J., Watt, J. P., Henkle, E., Deloria-Knoll, M., McCall, N., Lee, E., Mulholland, K., Levine, O. S., & Cherian, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61204-6 · Cited by 2,398
Self-citationWhitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Lynfield, R., Reingold, A., Cieslak, P. R., Pilishvili, T., Jackson, D., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022823 · Cited by 2,228
Hausdorff, W. P., Bryant, J., Paradiso, P. R., & Siber, G. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313608 · Cited by 866
Whitney, C. G., Pilishvili, T., Farley, M. M., Schaffner, W., Craig, A. S., Lynfield, R., Nyquist, A.-C., Gershman, K. A., Vazquez, M., Bennett, N. M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69637-2 · Cited by 623
Discovery of a New Capsular Serotype (6C) within Serogroup 6 of Streptococcus pneumoniae
Park, I. H., Pritchard, D. G., Cartee, R., Brandao, A., Brandileone, M. C. C., & Nahm, M. H. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02199-06 · Cited by 428
Genetic Basis for the New Pneumococcal Serotype, 6C
Park, I. H., Park, S., Hollingshead, S. K., & Nahm, M. H. (2007) · Infection and Immunity · doi:10.1128/iai.00510-07 · Cited by 164
Effects of Pneumococcal Conjugate Vaccine 2 Years after Its Introduction, the Netherlands
Rodenburg, G. D., de Greeff, S. C., Jansen, A. G. C. S., de Melker, H. E., Schouls, L. M., Hak, E., Spanjaard, L., Sanders, E. A. M., & van der Ende, A. (2010) · Emerging Infectious Diseases · doi:10.3201/eid1605.091223 · Cited by 159
Yaro, S., Lourd, M., Traoré, Y., Njanpop‐Lafourcade, B., Sawadogo, A., Sangaré, L., Hien, A., Ouedraogo, M. S., Sanou, O., du Châtelet, I. P., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/506940 · Cited by 134
Serotype replacement in perspective
Dagan, R. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.004 · Cited by 80
Lagos, R., Muñoz, A., Martin, O. S., Maldonado, A., Hormazábal, J. C., Blackwelder, W. C., & Levine, M. M. (2008) · The Journal of Infectious Diseases · doi:10.1086/593334 · Cited by 68
Standardizing Surveillance of Pneumococcal Disease
Knoll, M. D., Moïsi, J. C., Muhib, F., Wonodi, C. B., Lee, E. H., Grant, L. R., Gilani, Z., Anude, C., O’Brien, K. L., Cherian, T., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596480 · Cited by 31
Self-citationLevine, O. S., Cherian, T., Hajjeh, R. A., & Knoll, M. D. (2009) · Clinical Infectious Diseases · doi:10.1086/596479 · Cited by 28
Self-citationImöhl, M., Reinert, R. R., & van der Linden, M. (2010) · International Journal of Microbiology · doi:10.1155/2010/874189 · Cited by 25
Knoll, M. D., O’Brien, K. L., Henkle, E. M., Lee, E., Watt, J., McCall, N., & Mangtani, P. (2009) · Cited by 20
Self-citation
Cited by
Wahl, B., O'Brien, K. L., Greenbaum, A., Majumder, A., Liu, L., Chu, Y., Lukšić, I., Nair, H., McAllister, D. A., Campbell, H., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30247-x · Cited by 1,118
Self-citationO'Brien, K. L., Baggett, H. C., Brooks, W. A., Feikin, D. R., Hammitt, L. L., Higdon, M. M., Howie, S. R. C., Deloria Knoll, M., Kotloff, K. L., Levine, O. S., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30721-4 · Cited by 879
Self-citationThe fundamental link between pneumococcal carriage and disease
Simell, B., Auranen, K., Käyhty, H., Goldblatt, D., Dagan, R., O’Brien, K. L., & for the Pneumococcal Carriage Group (PneumoCarr) (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.53 · Cited by 633
Self-citationSatzke, C., Turner, P., Virolainen-Julkunen, A., Adrian, P. V., Antonio, M., Hare, K. M., Henao-Restrepo, A. M., Leach, A. J., Klugman, K. P., Porter, B. D., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.08.062 · Cited by 478
Self-citationBalsells, E., Guillot, L., Nair, H., & Kyaw, M. H. (2017) · PLOS ONE · doi:10.1371/journal.pone.0177113 · Cited by 393
Metadata
- Authors
- Johnson, H. L., Deloria-Knoll, M., Levine, O. S., Stoszek, S. K., Freimanis Hance, L., Reithinger, R., Muenz, L. R., & O'Brien, K. L.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-10-05
- Volume
- 7
- Issue
- 10
- Pages
- e1000348
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2029274790
- Cited by
- 551
- References
- 20
- FWCI
- 22.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.